Form 10-Q BioRestorative Therapies For: Mar 31
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Roth/MKM Reiterates Buy Rating on BioRestorative Therapies Inc. (BRTX)
June 12, 2024 2:48 PM EDTRoth/MKM analyst Jonathan Aschoff reiterated a Buy rating and $15.00 price target on BioRestorative Therapies Inc. (NASDAQ: BRTX)
The analyst comments "BRTX ended 1Q24 with $16.4M in cash. In February, BRTX released encouraging, preliminary, blinded Phase 2 results with BRTX-100 in the first four cLDD... More
